Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 309

1.

Amphiphysin-IgG autoimmune neuropathy: A recognizable clinicopathologic syndrome.

Dubey D, Jitprapaikulsan J, Bi H, Do Campo RV, McKeon A, Pittock SJ, Engelstad JK, Mills JR, Klein CJ.

Neurology. 2019 Oct 17. pii: 10.1212/WNL.0000000000008472. doi: 10.1212/WNL.0000000000008472. [Epub ahead of print]

PMID:
31624089
2.

Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica.

Burt RK, Balabanov R, Han X, Burns C, Gastala J, Jovanovic B, Helenowski I, Jitprapaikulsan J, Fryer JP, Pittock SJ.

Neurology. 2019 Oct 2. pii: 10.1212/WNL.0000000000008394. doi: 10.1212/WNL.0000000000008394. [Epub ahead of print]

PMID:
31578302
3.

Overnight loss of pigmented hair in autoimmune autonomic neuropathy treated with IVIg.

Turner LE, Pittock SJ, McEvoy MT, Flanagan EP.

Neurol Neuroimmunol Neuroinflamm. 2019 Sep 25;6(6). pii: e620. doi: 10.1212/NXI.0000000000000620. Print 2019 Nov. No abstract available.

4.

Reader response: Unintended consequences of Mayo paraneoplastic evaluations.

Pittock SJ, Mills JR, McKeon A.

Neurology. 2019 Sep 24;93(13):606. doi: 10.1212/WNL.0000000000008179. No abstract available.

PMID:
31551274
5.

Neurochondrin neurological autoimmunity.

Shelly S, Kryzer TJ, Komorowski L, Miske R, Anderson MD, Flanagan EP, Hinson SR, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2019 Sep 11;6(6). pii: e612. doi: 10.1212/NXI.0000000000000612. Print 2019 Nov.

6.

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.

Cree BAC, Bennett JL, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk DM, Fujihara K, Paul F, Cutter GR, Marignier R, Green AJ, Aktas O, Hartung HP, Lublin FD, Drappa J, Barron G, Madani S, Ratchford JN, She D, Cimbora D, Katz E; N-MOmentum study investigators.

Lancet. 2019 Oct 12;394(10206):1352-1363. doi: 10.1016/S0140-6736(19)31817-3. Epub 2019 Sep 5.

PMID:
31495497
7.

Optic neuritis in the era of biomarkers.

Chen JJ, Pittock SJ, Flanagan EP, Lennon VA, Bhatti MT.

Surv Ophthalmol. 2019 Aug 16. pii: S0039-6257(19)30246-2. doi: 10.1016/j.survophthal.2019.08.001. [Epub ahead of print] Review.

PMID:
31425702
8.

Seroprevalence and clinical phenotype of MOG-IgG-associated disorders in Sri Lanka.

Senanayake B, Jitprapaikulsan J, Aravinthan M, Wijesekera JC, Ranawaka UK, Riffsy MT, Paramanathan T, Sagen J, Fryer JP, Schmeling J, Majed M, Flanagan EP, Pittock SJ.

J Neurol Neurosurg Psychiatry. 2019 Aug 6. pii: jnnp-2018-320243. doi: 10.1136/jnnp-2018-320243. [Epub ahead of print] No abstract available.

9.

Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG.

Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Komorowski L, Scharf M, Hinson SR, Lennon VA, Pittock SJ, Klein CJ, McKeon A.

Neurology. 2019 Sep 3;93(10):e954-e963. doi: 10.1212/WNL.0000000000008061. Epub 2019 Aug 1. Erratum in: Neurology. 2019 Oct 1;93(14):647.

10.

Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity.

Zekeridou A, Kryzer T, Guo Y, Hassan A, Lennon V, Lucchinetti CF, Pittock S, McKeon A.

Neurology. 2019 Aug 20;93(8):e815-e822. doi: 10.1212/WNL.0000000000007971. Epub 2019 Jul 17.

11.

Testing for Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG) in typical MS.

Lopez-Chiriboga S, Pittock SJ, Weinshenker BG, Chen JJ, Flanagan E.

Mult Scler Relat Disord. 2019 Jun 29;35:34-35. doi: 10.1016/j.msard.2019.06.037. [Epub ahead of print] No abstract available.

PMID:
31299419
12.

Kelch-like Protein 11 Antibodies in Seminoma-Associated Paraneoplastic Encephalitis.

Mandel-Brehm C, Dubey D, Kryzer TJ, O'Donovan BD, Tran B, Vazquez SE, Sample HA, Zorn KC, Khan LM, Bledsoe IO, McKeon A, Pleasure SJ, Lennon VA, DeRisi JL, Wilson MR, Pittock SJ.

N Engl J Med. 2019 Jul 4;381(1):47-54. doi: 10.1056/NEJMoa1816721.

PMID:
31269365
13.

Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology.

Sechi E, Shosha E, Williams JP, Pittock SJ, Weinshenker BG, Keegan BM, Zalewski NL, Lopez-Chiriboga AS, Jitprapaikulsan J, Flanagan EP.

Neurology. 2019 Jul 23;93(4):e414-e420. doi: 10.1212/WNL.0000000000007828. Epub 2019 Jun 24.

PMID:
31235660
14.

Ethical considerations of maternal-fetal intervention in a twin pregnancy discordant for anomalies.

Riggan KA, Collura CA, Pittock ST, Ruano R, Whitford KJ, Allyse M.

J Matern Fetal Neonatal Med. 2019 Jun 20:1-6. doi: 10.1080/14767058.2019.1631793. [Epub ahead of print]

PMID:
31189438
15.

GABAA receptor autoimmunity: A multicenter experience.

O'Connor K, Waters P, Komorowski L, Zekeridou A, Guo CY, Mgbachi VC, Probst C, Mindorf S, Teegen B, Gelfand JM, Geschwind MD, Lennon V, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2019 Apr 4;6(3):e552. doi: 10.1212/NXI.0000000000000552. eCollection 2019 May.

16.

Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up.

Petzold A, Woodhall M, Khaleeli Z, Tobin WO, Pittock SJ, Weinshenker BG, Vincent A, Waters P, Plant GT.

J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):1021-1026. doi: 10.1136/jnnp-2019-320493. Epub 2019 May 22.

PMID:
31118222
17.

Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.

Pittock SJ, Berthele A, Fujihara K, Kim HJ, Levy M, Palace J, Nakashima I, Terzi M, Totolyan N, Viswanathan S, Wang KC, Pace A, Fujita KP, Armstrong R, Wingerchuk DM.

N Engl J Med. 2019 Aug 15;381(7):614-625. doi: 10.1056/NEJMoa1900866. Epub 2019 May 3.

PMID:
31050279
18.

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders.

Palace J, Lin DY, Zeng D, Majed M, Elsone L, Hamid S, Messina S, Misu T, Sagen J, Whittam D, Takai Y, Leite MI, Weinshenker B, Cabre P, Jacob A, Nakashima I, Fujihara K, Pittock SJ.

Brain. 2019 May 1;142(5):1310-1323. doi: 10.1093/brain/awz054.

19.

Patterns of amiodarone-induced thyroid dysfunction in infants and children.

Creo A, Anderson H, Cannon B, Lteif A, Kumar S, Tebben P, Iqbal AM, Ramakrishna A, Pittock S.

Heart Rhythm. 2019 Sep;16(9):1436-1442. doi: 10.1016/j.hrthm.2019.03.015. Epub 2019 Mar 21.

PMID:
30904484
20.

Isolated recurrent myelitis in a persistent MOG positive patient.

Anis S, Regev K, Pittock SJ, Flanagan EP, Alcalay Y, Gadoth A.

Mult Scler Relat Disord. 2019 May;30:163-164. doi: 10.1016/j.msard.2019.02.016. Epub 2019 Feb 13.

PMID:
30780123
21.

A mouse model of seizures in anti-N-methyl-d-aspartate receptor encephalitis.

Taraschenko O, Fox HS, Pittock SJ, Zekeridou A, Gafurova M, Eldridge E, Liu J, Dravid SM, Dingledine R.

Epilepsia. 2019 Mar;60(3):452-463. doi: 10.1111/epi.14662. Epub 2019 Feb 11.

PMID:
30740690
22.

A multicenter comparison of MOG-IgG cell-based assays.

Waters PJ, Komorowski L, Woodhall M, Lederer S, Majed M, Fryer J, Mills J, Flanagan EP, Irani SR, Kunchok AC, McKeon A, Pittock SJ.

Neurology. 2019 Mar 12;92(11):e1250-e1255. doi: 10.1212/WNL.0000000000007096. Epub 2019 Feb 6.

23.

Antibody Prevalence in Epilepsy and Encephalopathy score: Increased specificity and applicability.

Dubey D, Pittock SJ, McKeon A.

Epilepsia. 2019 Feb;60(2):367-369. doi: 10.1111/epi.14649. No abstract available.

PMID:
30727035
24.

Episodic ataxia in CASPR2 autoimmunity.

López Chiriboga AS, Pittock S.

Neurol Neuroimmunol Neuroinflamm. 2018 Dec 24;6(2):e536. doi: 10.1212/NXI.0000000000000536. eCollection 2019 Mar. No abstract available.

25.

Optical coherence tomography is highly sensitive in detecting prior optic neuritis.

Xu SC, Kardon RH, Leavitt JA, Flanagan EP, Pittock SJ, Chen JJ.

Neurology. 2019 Feb 5;92(6):e527-e535. doi: 10.1212/WNL.0000000000006873. Epub 2019 Jan 23.

PMID:
30674600
26.

Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody.

Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, Weinshenker BG, Shosha E, Lucchinetti CF, Fryer JP, Lopez-Chiriboga AS, Chen JC, Jitprapaikulsan J, McKeon A, Gadoth A, Keegan BM, Tillema JM, Naddaf E, Patterson MC, Messacar K, Tyler KL, Flanagan EP.

JAMA Neurol. 2019 Mar 1;76(3):301-309. doi: 10.1001/jamaneurol.2018.4053.

PMID:
30575890
27.

Author Correction: Neuroimmune disorders of the central nervous system in children in the molecular era.

Wells E, Hacohen Y, Waldman A, Tillema JM, Soldatos A, Ances B, Benseler S, Bielekova B, Dale RC, Dalmau J, Gaillard W, Gorman M, Greenberg B, Hyslop A, Pardo CA, Tasker RC, Yeh EA, Bar-Or A, Pittock S, Vanderver A, Banwell B; attendees of the International Neuroimmune Meeting.

Nat Rev Neurol. 2018 Dec;14(12):749. doi: 10.1038/s41582-018-0077-9.

PMID:
30442924
28.

Improved utilization of waist-to-height ratio in cardiometabolic risk counselling in children: Application of DMAIC strategy.

Gupta N, Lteif A, Creo A, Iqbal AM, Pittock S, Tebben PJ, Hansen J, Heyrman M, Spee R, Scanlan-Hanson L, Kumar S.

J Eval Clin Pract. 2019 Apr;25(2):300-305. doi: 10.1111/jep.13055. Epub 2018 Oct 31.

PMID:
30378218
29.

The Authors' Reply: Diagnostic accuracy of the McGill thyroid nodule score in pediatric patients: methodological issues.

Creo A, Alahdab F, Al Nofal A, Thomas K, Kolbe A, Pittock S.

Clin Endocrinol (Oxf). 2019 Feb;90(2):385. doi: 10.1111/cen.13893. Epub 2018 Nov 26. No abstract available.

PMID:
30374996
30.

Diagnostic accuracy of the McGill thyroid nodule score in paediatric patients.

Creo A, Alahdab F, Al Nofal A, Thomas K, Kolbe A, Pittock S.

Clin Endocrinol (Oxf). 2019 Jan;90(1):200-207. doi: 10.1111/cen.13878. Epub 2018 Nov 12.

PMID:
30326152
31.

Age is a critical determinant in recovery from multiple sclerosis relapses.

Conway BL, Zeydan B, Uygunoğlu U, Novotna M, Siva A, Pittock SJ, Atkinson EJ, Rodriguez M, Kantarci OH.

Mult Scler. 2018 Oct 10:1352458518800815. doi: 10.1177/1352458518800815. [Epub ahead of print]

PMID:
30303037
32.

Paraneoplastic neuronal intermediate filament autoimmunity.

Basal E, Zalewski N, Kryzer TJ, Hinson SR, Guo Y, Dubey D, Benarroch EE, Lucchinetti CF, Pittock SJ, Lennon VA, McKeon A.

Neurology. 2018 Oct 30;91(18):e1677-e1689. doi: 10.1212/WNL.0000000000006435. Epub 2018 Oct 3.

33.

Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG-positive NMOSD.

Shosha E, Dubey D, Palace J, Nakashima I, Jacob A, Fujihara K, Takahashi T, Whittam D, Leite MI, Misu T, Yoshiki T, Messina S, Elsone L, Majed M, Flanagan E, Gadoth A, Huebert C, Sagen J, Greenberg BM, Levy M, Banerjee A, Weinshenker B, Pittock SJ.

Neurology. 2018 Oct 23;91(17):e1642-e1651. doi: 10.1212/WNL.0000000000006392. Epub 2018 Sep 26.

34.

Pain and the immune system: emerging concepts of IgG-mediated autoimmune pain and immunotherapies.

Xu M, Bennett DLH, Querol LA, Wu LJ, Irani SR, Watson JC, Pittock SJ, Klein CJ.

J Neurol Neurosurg Psychiatry. 2018 Sep 17. pii: jnnp-2018-318556. doi: 10.1136/jnnp-2018-318556. [Epub ahead of print]

PMID:
30224548
35.

Population-based study of "no evident disease activity" in MS.

Parks NE, Pittock SJ, Mandrekar J, Kantarci OH, Lucchinetti CF, Weinshenker BG, Keegan BM, Tobin WO, Tillema JM, Toledano M, Flanagan EP.

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 16;5(6):e495. doi: 10.1212/NXI.0000000000000495. eCollection 2018 Nov.

36.

Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction.

Dubey D, Kothapalli N, McKeon A, Flanagan EP, Lennon VA, Klein CJ, Britton JW, So E, Boeve BF, Tillema JM, Sadjadi R, Pittock SJ.

J Neuroimmunol. 2018 Oct 15;323:62-72. doi: 10.1016/j.jneuroim.2018.07.009. Epub 2018 Jul 25.

PMID:
30196836
37.

Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine-rich glioma-inactivated protein 1.

Feyissa AM, Lamb C, Pittock SJ, Gadoth A, McKeon A, Klein CJ, Britton JW.

Epilepsia Open. 2018 Jun 25;3(3):348-356. doi: 10.1002/epi4.12226. eCollection 2018 Sep.

38.

Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1.

Mammen AL, Rajan A, Pak K, Lehky T, Casciola-Rosen L, Donahue RN, Lepone LM, Zekeridou A, Pittock SJ, Hassan R, Schlom J, Gulley JL.

Ann Rheum Dis. 2019 Jan;78(1):150-152. doi: 10.1136/annrheumdis-2018-213777. Epub 2018 Sep 5. No abstract available.

PMID:
30185415
39.

Posttransplant autoimmune encephalitis.

Cohen DA, Lopez-Chiriboga AS, Pittock SJ, Gadoth A, Zekeridou A, Boilson BA, Hogan WJ, Poterucha JJ, Wilton KM, Lin Y, Flanagan EP.

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 20;5(6):e497. doi: 10.1212/NXI.0000000000000497. eCollection 2018 Nov. No abstract available.

40.

LGI1 and CASPR2 neurological autoimmunity in children.

López-Chiriboga AS, Klein C, Zekeridou A, McKeon A, Dubey D, Flanagan EP, Lennon VA, Tillema JM, Wirrell EC, Patterson MC, Gadoth A, Aaen JG, Brenton JN, Bui JD, Moen A, Otten C, Piquet A, Pittock SJ.

Ann Neurol. 2018 Sep;84(3):473-480. doi: 10.1002/ana.25310.

PMID:
30076629
41.

Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.

Chen JJ, Flanagan EP, Jitprapaikulsan J, López-Chiriboga ASS, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, Lee MS, Bennett JL, Pelak VS, Chen Y, VanStavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Brazis PW, Sagen J, Pittock SJ.

Am J Ophthalmol. 2018 Nov;195:8-15. doi: 10.1016/j.ajo.2018.07.020. Epub 2018 Jul 26.

42.

Spontaneous posterior spinal artery infarction: An under-recognized cause of acute myelopathy.

Zalewski NL, Rabinstein AA, Wijdicks EFM, Petty GW, Pittock SJ, Mantyh WG, Flanagan EP.

Neurology. 2018 Aug 28;91(9):414-417. doi: 10.1212/WNL.0000000000006084. Epub 2018 Jul 25. No abstract available.

PMID:
30045962
43.

Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis.

Sechi E, Morris PP, McKeon A, Pittock SJ, Hinson SR, Weinshenker BG, Aksamit AJ, Krecke KN, Kaufmann TJ, Jolliffe EA, Zalewski NL, Zekeridou A, Wingerchuk DM, Jitprapaikulsan J, Flanagan EP.

J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):488-490. doi: 10.1136/jnnp-2018-318004. Epub 2018 Jul 21. No abstract available.

PMID:
30032117
44.

Ultrasonography and the American Thyroid Association Ultrasound-Based Risk Stratification Tool: Utility in Pediatric and Adolescent Thyroid Nodules.

Creo A, Alahdab F, Al Nofal A, Thomas K, Kolbe A, Pittock ST.

Horm Res Paediatr. 2018;90(2):93-101. doi: 10.1159/000490468. Epub 2018 Jul 18.

45.

Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.

López-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, Jitprapaikulsan J, Kothapalli N, Tillema JM, Chen J, Weinshenker B, Wingerchuk D, Sagen J, Gadoth A, Lennon VA, Keegan BM, Lucchinetti C, Pittock SJ.

JAMA Neurol. 2018 Nov 1;75(11):1355-1363. doi: 10.1001/jamaneurol.2018.1814.

46.

Autoimmune septin-5 cerebellar ataxia.

Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Fryer JP, Devine M, Flores A, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2018 Jul 9;5(5):e474. doi: 10.1212/NXI.0000000000000474. eCollection 2018 Sep. Erratum in: Neurol Neuroimmunol Neuroinflamm. 2018 Dec 12;6(1):e534.

47.

Thyroid storm after choking.

Creo AL, Cannon BC, Pittock ST.

J Pediatr Endocrinol Metab. 2018 Aug 28;31(8):933-936. doi: 10.1515/jpem-2018-0072.

PMID:
29935115
48.

Neuroimmune disorders of the central nervous system in children in the molecular era.

Wells E, Hacohen Y, Waldman A, Tillema JM, Soldatos A, Ances B, Benseler S, Bielekova B, Dale RC, Dalmau J, Gaillard W, Gorman M, Greenberg B, Hyslop A, Pardo CA, Tasker RC, Yeh EA, Bar-Or A, Pittock S, Vanderver A, Banwell B; attendees of the International Neuroimmune Meeting.

Nat Rev Neurol. 2018 Jul;14(7):433-445. doi: 10.1038/s41582-018-0024-9. Review. Erratum in: Nat Rev Neurol. 2018 Dec;14(12):749.

PMID:
29925924
49.

Mild subclinical hypothyroidism is associated with paediatric dyslipidaemia.

Dahl AR, Iqbal AM, Lteif AN, Pittock ST, Tebben PJ, Kumar S.

Clin Endocrinol (Oxf). 2018 Sep;89(3):330-335. doi: 10.1111/cen.13752. Epub 2018 Jun 21.

PMID:
29846957
50.

Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1 year.

Dubey D, Hinson SR, Jolliffe EA, Zekeridou A, Flanagan EP, Pittock SJ, Basal E, Drubach DA, Lachance DH, Lennon VA, McKeon A.

J Neuroimmunol. 2018 Aug 15;321:157-163. doi: 10.1016/j.jneuroim.2018.04.016. Epub 2018 Apr 27.

PMID:
29793728

Supplemental Content

Loading ...
Support Center